Primary Objective
To compare the prevalence of ototoxicity and neurotoxicity in GCT cancer survivors who only had surgery to a similar population from The Platinum Study (RSRB45410/1305011509) who received cisplatin-based combination chemotherapy.
Secondary Objective
To compare the prevalence of obesity, hypertension, and use of antidepressants/anxiolytics in GCT cancer survivors who only had surgery to a similar population from The Platinum Study who received cisplatin-based combination chemotherapy.
Inclusion Criteria:
* Diagnosis or confirmation of diagnosis of a histologically or serologically confirmed testicular germ cell tumor (GCT) or GCT at another anatomic location
* Age at GCT diagnosis: 55 years of age or younger
* Males, 18 years of age or older at time of study consent
* Subject is able to provide consent
* Subject is able to speak and read English
* Treatment consisted of surgery only (i.e., orchiectomy and/or retroperitoneal lymph node dissection \[RPLND\]) for either initial testicular germ cell tumor (GCT) or subsequent testicular cancer
* Subject completed surgery \> 1 year ago
* Subject is currently undergoing active follow-up at IU
* Subject did not require any subsequent chemotherapy, salvage chemotherapy treatment or bone marrow transplant.
* Subject had no prior chemotherapy of any kind
Exclusion Criteria:
* Patients with prior chemotherapy (whether for GCT or any other cancer)
Any Site
Other Male Genital
